Thank you: solidarity in the global fight against the novel coronavirus

Around the world, we are working with urgency, passion and purpose each and every day to improve the situation and help each other amidst an unprecedented global pandemic.

We bravely continue to work around the clock to ensure that patients receive our medicines and solutions as fast as possible. It is uncharted territory with many challenges but we are determined to continue providing healthcare systems, communities and individuals the tools they need to overcome COVID-19. There are many unknowns. But one thing is certain: we are stronger together.

COVID-19: Global partnership for a global health emergency

Read the perspectives of those involved in the COVID-19 response on how the evolving pandemic has required a multifaceted, collaborative approach.

Data can change your life; it probably already has

How data can improve and save lives, and why it matters during the COVID-19 crisis and beyond.

Pharma Technical Operations delivers for patients during COVID-19

Making biologics is complicated under the best circumstances. But in the midst of a pandemic, Roche & Genentech teams are doing it faster than ever.

Fighting COVID-19 with the Train Of Hope

The Roche-sponsored Phelophepa healthcare trains have joined the COVID-19 response.

Serendipity put Larry Tsai in the right place at the right time

About a year ago, Larry Tsai became Global Head of Respiratory and Rheumatology Product Development at Roche. Some six months later, the pandemic arrived.

A clinical study of pandemic proportions

Setting up robust clinical trials can take six months or even a year. A Roche team did it in 15 days during the pandemic.

‘It doesn’t get any closer to home than this’ Michaela Hart is usually a customer champion. This time she and her daughter were the customers

Nearly three years ago, Michaela Hart’s daughter was diagnosed with cancer. But after yet another hospital visit, something seemed off.

The future hinges on partnerships

Call it what you will – a near-death experience, a revelation, an awakening. But when you talk with Alain Bindels, you’ll find a man changed by COVID-19.

Clinical trials 101

A Roche biostatistician explains what happens in rigorous clinical trials, and why not all studies provide the same quality of information.

“A broken world needs examples of a better way”

Roche Pharma CEO Bill Anderson on moments of laughter and learnings during lockdown.

A global health crisis inspires unique partnerships

In the race to detect and treat COVID-19, biotech, government and academia are joining forces to battle a disease that knows no borders.

COVID-19 and the mysterious world of antibodies

Timothy Tellinghuisen, Head of Virology Discovery, explains why understanding antibodies could hold the key in tackling COVID-19 and other pandemics.

Do not lose the lesson that science and societal action gives us

When we foster a culture of global collaboration, anything is possible, says Roche Pharmaceuticals CEO Bill Anderson.

Taking it off the ground

This clinical trial had to start quickly to test if an old Roche drug helped serious COVID-19 patients. A Roche veteran is coordinating these efforts.

Researching the coronavirus in the search for solutions

Head of Infectious Diseases at Roche Pharma Early Research & Development, John Young shares his insights on the biology of covid-19 and outlook on future cures.

The double risk of vulnerable populations and COVID-19

The elderly and those with mental diseases are the largely silent and sometimes overlooked victims of the pandemic.

Everyday heroes working around the clock

Tirelessly, Roche sites around the world continue to make medicines and tests people need and rely on today, and seek solutions for a better tomorrow.

From local to global, together we are stronger

Roche is partnering with governments, agencies and organisations large and small to overcome a worldwide health crisis in distinctly local ways.

Stories of solidarity

No act is too small in the fight against COVID-19. Across our organisation, resourceful employees are using any available tools to support the effort.

Roche colleagues adapt to the new normal: working from home

As much of the Roche workforce navigates the challenges of suddenly working from home during COVID-19, they share their insights on keeping connected.

Are men more affected by the novel coronavirus than women?

Roche neuroscientist Antonella Santuccione Chadha explores how sex and gender differences in the disease can help propel precision medicine forward.

Roche has faced and weathered many challenges in its near 125 years. The solidarity and community we experience now will bring us closer together, and there is no doubt that we will come out of this even stronger.”
Severin Schwan Roche CEO